BIOXYTRAN, INC
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Legal Proceedings
Item 1. Legal Proceedings
On December 29, 2025, the Company terminated an officer for cause. The officer has contested all allegations and has, so far, submitted a worker rights complaint with the State of Washington Department of Labor and Industries (the “Department”), which the Company has contested as having no foundation or basis in fact.
On April 30, 2026, the Company was informed that the Department had sided with the plaintive and on June 11, 2026, the Company was informed that the initial appeal concerning the investigation by the Department had determined that the worker rights complaint filed by a former officer was justified and assessed the Balance of Wages, Interest & NSF Fee Due to $186,960.97 with an interest accrual of 1% per month. The Company made an additional appeal claiming that the Departments decision as having no foundation or basis in fact and strongly believe it will be successful in its claim. Never the less, the Company’s recorded reserves should cover the assessed amount and will not affect future results.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.